# OnCo record sara-tolaney (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/sara-tolaney/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "sara-tolaney" ;
  schema:name "Sara M. Tolaney"@en ;
  schema:description "Leads Dana-Farber's breast oncology division and many of the trials that moved ADCs and de-escalated therapy into breast cancer care."@en ;
  schema:url <https://onco.cc/people/sara-tolaney/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.dana-farber.org/find-a-doctor/sara-m-tolaney>, <https://pubmed.ncbi.nlm.nih.gov/?term=Tolaney%20SM%5BAuthor%5D> ;
  schema:jobTitle "Chief, Division of Breast Oncology; Associate Director, Susan F. Smith Center for Women's Cancers" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/trop2/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/datopotamab-deruxtecan/>, <https://onco.cc/drugs/sacituzumab-govitecan/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/> ;
  onco:trials <https://onco.cc/trials/apt-trial/>, <https://onco.cc/trials/tropion-breast01/>, <https://onco.cc/trials/destiny-breast09/> ;
  schema:affiliation <https://onco.cc/institutions/dana-farber/> .